The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin

Amol M. Patwardhan, Nathaniel A. Jeske, Theodore J. Price, Nikita Gamper, Armen N. Akopian, Kenneth M. Hargreaves

Research output: Contribution to journalArticlepeer-review

132 Scopus citations

Fingerprint

Dive into the research topics of 'The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin'. Together they form a unique fingerprint.

Medicine & Life Sciences